摘要
目的:建立HPLC-MS/MS测定大鼠血浆中泽泻醇A-24-醋酸酯浓度的方法,比较单味药泽泻与复方花旗泽仁中有效成分——泽泻醇A-24-醋酸酯在大鼠体内的药代动力学差异,评价配伍对泽泻醇A-24-醋酸酯的动力学影响。方法:雄性SD大鼠12只,随机分为泽泻组与花旗泽仁组,灌胃给药后在不同时间点进行采血,采用DAS2. 0数据处理软件的非房室模型法(统计矩法)计算药代动力学参数。结果:泽泻单独给药时泽泻醇A-24-醋酸酯最大浓度(Cmax)为(71. 88±13. 43)μg/L;达峰时间(T_(max))为0. 50 h;半衰期(t_(1/2))为(6. 065±2. 246) h;浓度-时间曲线下面积(AUC0-t)为(350. 60±47. 70)μg/(L·h);平均驻留时间(MRT0-t)为(7. 644±0. 692) h;清除率(CL)为(0. 397 7±0. 056 9)L/(h·kg);配伍后泽泻醇A-24-醋酸酯Cmax为(67. 46±22. 10)μg/L; T_(max)为1 h; t_(1/2)为(5. 543±1. 515) h; AUC0-t为(492. 50±69. 79)μg/(L·h); MRT0-t为(7. 667±1. 127) h; CL为(0. 288 5±0. 047 4) L/(h·kg)。结果:花旗泽仁组中泽泻醇A-24-醋酸酯的浓度-时间曲线下面积和清除率与泽泻组比较有显著性差异(P <0. 05),其他参数比较均无显著性差异(P> 0. 05)。结论:配伍后泽泻醇A-24-醋酸酯药时曲线依然存在明显的双峰现象;泽泻配伍为花旗泽仁可使泽泻醇A-24-醋酸酯在大鼠体内起效时间延长,吸收程度增加,血浆清除率降低。
Objective : To establish HPLC - MS/MS method for the determination of alisol A - 24 - acetate in rats' plasma, and to compare the pharmacokinetic differences of alisol A -24 - acetate from single herb of Zexie (Rhizoma alismatis) and from Huaqizeren formula, thus to evaluate the effect of compatibility on the ki- netics of alisol A - 24 - acetate. Methods : 12 male SD rats were randomly divided into Zexie group and Hua- qizeren group. Blood samples were collected at different time points after gavage administration. The pharma-cokinetic parameters were calculated by DAS 2.0 software( statistics moment method). concentration of alisol A - 24 - acetate(C ) was (71.88 ±13.43) μg/L, the peak Results : The maximum time(T ) was0.50 h and the half life time ( t1/2 ) was (6. 065 ± 2. 246 ) h; the area under the concentration - time cure-e ( AUG0 -t ) was (350.60 ±47.70) μg/(L · h) ; mean residence time(MRT0-t) was (7. 644 ±0. 692) h; clearance rate (CL) was (0. 397 7 ±0. 056 9)L/(h · kg); after the compatibility, C of alisol A -24 -acetate was (67.46 ±22.10) μg/L; T was 1 h; t1/2 was (5. 543 ± 1. 515) h; AUG0-t was (492.50 ± 69. 79) μg/(L · h) ; MRT0-t was (7.667 ±1. 127) h; CL was (0.288 5 ±0.047 4) L/(h · kg). Results: AUG0-t and CL of alisol A - 24 - acetate in Huaqizeren group were significantly different from those in the Zexie group (P 〈 0.05), and no significant differences were found in temps of other parameters (P 〉 0.05 ). Conclusion : There is still a phenomenon of bimodal distribution in the curve of alisol - A - 24 - acetate after the compatibility. Compatibility of Rhizoma alismatis makes the effect of alisol A - 24 - acetate longer, increases its absorption and reduces its plasma clearance.
作者
李嘉欣
韩东卫
朱蕾
葛鹏玲
LI Jiaxin;HAN Dongwei;ZHU Lei;GE Pengling(Heilongjiang University of Chinese Medicine,Habin 150040,China)
出处
《中医药信息》
2018年第5期41-46,共6页
Information on Traditional Chinese Medicine
基金
国家自然科学基金项目(No.81273650)
国家科技重大专项(No.2012ZX09103201-018)
黑龙江省自然科学基金项目(No.LC2011C03)
黑龙江中医药大学"优秀创新人才支持计划"(No.2012RCD19)
黑龙江中医药大学科研基金项目(No.201515)
黑龙江中医药大学研究生创新科研项目(No.yjscx2017015)
黑龙江省博士后科研启动基金项目(No.LBH-Q15136)
哈尔滨市科技创新人才研究专项资金项目(No.2016RAXXJ100)
黑龙江省中医药科研项目(No.ZHY16-093)